Regulatory Alerts2020-03-19 | ASFI/CC-2561/2020Added · Updated
ASFI Circular Letter DNP CC-2561 2020 of March 19, 2020
Financial intermediation entities are instructed to provide timely attention to current and subsequent requests for the issuance of Guarantee Letters and First-Demand Guarantees from laboratories and national pharmaceutical manufacturing companies that are part of the Bolivian Pharmaceutical Industry Chamber (CIFABOL). This directive applies to entities operating within the Plurinational State of Bolivia under the national health emergency declared by Supreme Decree No. 4196.
Topics
Share